View Cart (0 items)
Pharmaceutical

Report delivers ROI analysis on key lifecycle management strategies used in pharmaceutical industry

February 28, 2012
/ Print / Reprints /
| Share More
/ Text Size+

CHAPEL HILL, N.C. — Strategies to extend the commercial life of mature brands are critical to today''s pharmaceutical industry. Used correctly, lifecycle management strategies can add as many as 10 years and billions of dollars to the life of an established or mature brand, says a new study from Best Practices, LLC.

The new study, "Lifecycle Management Excellence: High-Performing Strategies Used to Maximize Potential of Mature Brands," helps biopharmaceutical companies more effectively conduct the many activities related to lifecycle management.

The report delivers hard-to-find benchmarks around the implementation time, cost and ROI of frequently used lifecycle management strategies. It also provides benchmarks on the optimal size and structure of Mature Brand Organizations, as well as the barriers and regulations affecting the strategies used by Mature Brand Organizations.

You must login or register in order to post a comment.